跳至主要内容
临床试验/NL-OMON54534
NL-OMON54534招募中不适用

Permanent left ventricular septal pacing versus right ventricular pacing in patients with atrioventricular conduction disorders: a randomized trial: LEAP trial. - LEAP trial.

niversiteit Maastricht0 个研究点目标入组 400 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >=18 years with a life expectancy with good functional status of at least
  • - Class I or class IIa permanent pacing indication owing to an AV conduction
  • disorder with an expected ventricular pacing percentage of >= 20%. AV conduction
  • disorders include:
  • - acquired third- or second-degree AV block.
  • - atrial arrhythmia with slow ventricular conduction.
  • - LVEF >= 40%.
  • - Signed and dated informed consent form prior to admission to the trial.

排除标准

  • - Heart failure NYHA class III-IV
  • - Class I indication for cardiac resynchronization therapy
  • - Class I indication for implantable cardioverter defibrillator
  • - Previous receipt of a cardiac implantable electronic device (except for
  • implantable loop recorders)
  • - Atrial arrhythmia with planned AV junction ablation
  • - Unstable angina or acute myocardial infarction
  • - Percutaneous or surgical coronary intervention within 30 days before
  • - Valvular disease with an indication for valve repair or replacement
  • - Hypertrophic cardiomyopathy with septal wall diameter > 2 cm
  • - Renal insufficiency requiring hemodialysis
  • - Active infectious disease or malignancy
  • - Women who are pregnant

研究者

相似试验

Permanent left ventricular septal pacing versus... | 临床试验